Barclays’s Tenet Healthcare THC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-49,400
| Closed | -$3.25M | – | 5349 |
|
|
2023
Q3 | $3.25M | Buy |
+49,400
| New | +$3.69M | ﹤0.01% | 1589 |
|
|
2022
Q1 | – | Sell |
-1,400
| Closed | -$114K | – | 5592 |
|
|
2021
Q4 | $114K | Buy |
+1,400
| New | +$102K | ﹤0.01% | 3704 |
|
|
2021
Q1 | – | Sell |
-3,200
| Closed | -$128K | – | 5178 |
|
|
2020
Q4 | $128K | Hold |
3,200
| – | – | ﹤0.01% | 4013 |
|
|
2020
Q3 | $78K | Hold |
3,200
| – | – | ﹤0.01% | 4375 |
|
|
2020
Q2 | $58K | Sell |
3,200
-11,500
| -78% | -$227K | ﹤0.01% | 4860 |
|
|
2020
Q1 | $212K | Sell |
14,700
-9,400
| -39% | -$270K | ﹤0.01% | 4251 |
|
|
2019
Q4 | $917K | Sell |
24,100
-24,100
| -50% | -$722K | ﹤0.01% | 3752 |
|
|
2019
Q3 | $1.07M | Buy |
48,200
+14,200
| +42% | +$303K | ﹤0.01% | 3612 |
|
|
2019
Q2 | $702K | Buy |
34,000
+16,600
| +95% | +$383K | ﹤0.01% | 4035 |
|
|
2019
Q1 | $502K | Sell |
17,400
-56,700
| -77% | -$1.4M | ﹤0.01% | 4115 |
|
|
2018
Q4 | $1.27M | Sell |
74,100
-8,700
| -11% | -$211K | ﹤0.01% | 2876 |
|
|
2018
Q3 | $2.36M | Sell |
82,800
-353,200
| -81% | -$11.7M | ﹤0.01% | 2692 |
|
|
2018
Q2 | $14.6M | Buy |
436,000
+131,800
| +43% | +$4.1M | 0.01% | 976 |
|
|
2018
Q1 | $7.38M | Buy |
304,200
+178,600
| +142% | +$3.56M | 0.01% | 1354 |
|
|
2017
Q4 | $1.9M | Sell |
125,600
-58,500
| -32% | -$823K | ﹤0.01% | 2478 |
|
|
2017
Q3 | $3.02M | Buy |
184,100
+113,500
| +161% | +$1.92M | ﹤0.01% | 1953 |
|
|
2017
Q2 | $1.36M | Sell |
70,600
-123,300
| -64% | -$2.15M | ﹤0.01% | 2601 |
|
|
2017
Q1 | $3.43M | Buy |
193,900
+169,600
| +698% | +$3.15M | ﹤0.01% | 1609 |
|
|
2016
Q4 | $361K | Buy |
24,300
+8,000
| +49% | +$144K | ﹤0.01% | 3670 |
|
|
2016
Q3 | $369K | Sell |
16,300
-32,000
| -66% | -$833K | ﹤0.01% | 3484 |
|
|
2016
Q2 | $1.33M | Sell |
48,300
-16,100
| -25% | -$476K | ﹤0.01% | 2358 |
|
|
2016
Q1 | $1.8M | Sell |
64,400
-61,700
| -49% | -$1.61M | ﹤0.01% | 2006 |
|
|
2015
Q4 | $3.78M | Buy |
126,100
+107,000
| +560% | +$3.51M | ﹤0.01% | 1512 |
|
|
2015
Q3 | $688K | Sell |
19,100
-66,800
| -78% | -$3.45M | ﹤0.01% | 3066 |
|
|
2015
Q2 | $4.9M | Buy |
85,900
+60,600
| +240% | +$3.1M | 0.01% | 1497 |
|
|
2015
Q1 | $1.24M | Buy |
25,300
+1,700
| +7% | +$79.5K | ﹤0.01% | 2772 |
|
|
2014
Q4 | $1.18M | Sell |
23,600
-945,800
| -98% | -$49.4M | ﹤0.01% | 3052 |
|
|
2014
Q3 | $57.2M | Sell |
969,400
-75,200
| -7% | -$4.2M | 0.06% | 282 |
|
|
2014
Q2 | $48.1M | Buy |
1,044,600
+1,013,600
| +3,270% | +$45.8M | 0.05% | 324 |
|
|
2014
Q1 | $1.3M | Buy |
31,000
+2,175
| +8% | +$96K | ﹤0.01% | 2951 |
|
|
2013
Q4 | $1.21M | Buy |
28,825
+5,600
| +24% | +$244K | ﹤0.01% | 3179 |
|
|
2013
Q3 | $952K | Sell |
23,225
-7,200
| -24% | -$301K | ﹤0.01% | 3397 |
|
|
2013
Q2 | $1.4M | Buy |
+30,425
| New | +$1.36M | ﹤0.01% | 2948 |
|
Other funds holding THC
VPM
VCM
LPC
Barclays's THC Position: Q1 2026 in Review
Barclays reduced its Tenet Healthcare (THC) stake by 32% in Q1 2026, selling an estimated $6.28M and leaving 64,342 shares worth $12.1M. The position accounts for ﹤0.01% of the portfolio, ranked #1348.
Barclays first reported a position in THC in Q2 2013 and has held it in 52 quarters since. The position peaked at $83M in Q2 2022. 691 funds tracked by Wall St. Rank hold THC as of Q1 2026.
- Barclays held 64,342 shares of Tenet Healthcare worth $12.1M as of Q1 2026.
- Barclays sold 29,817 Tenet Healthcare shares in Q1 2026, an estimated $6.28M.
- Tenet Healthcare made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #1348 holding.
- Barclays first reported a position in Tenet Healthcare in Q2 2013 and has held it in 52 quarters since.
- Barclays's Tenet Healthcare position peaked at $83M in Q2 2022.
- 691 funds tracked by Wall St. Rank held Tenet Healthcare as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.